Drug Trial Radar · NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,500
Planned (sponsor's estimate)
Start
Aug 20, 2026
Primary completion
Aug 9, 2028
Study completion Aug 9, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment
Conditions
- Obesity or Overweight
- Diabetes Mellitus, Type 2
Interventions
LenbelintideDrug
IMP injected subcutaneously, once a week. Unit dose strength as per CSP.
PlaceboDrug
Placebo matching IMP dose injected subcutaneously, once a week.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in body weight from baseline at 68 weeks of treatment.Time frame: 68 weeks
Locations
230 sites in 16 countries. Site status is shown where the registry gives one.
Research Site
Fairhope, Alabama · Recruiting
Research Site
Huntsville, Alabama · Not yet recruiting
Research Site
Mobile, Alabama · Not yet recruiting
Research Site
Mesa, Arizona · Not yet recruiting
Research Site
Phoenix, Arizona · Recruiting
Research Site
Tucson, Arizona · Not yet recruiting
Research Site
Little Rock, Arkansas · Not yet recruiting
Research Site
Bakersfield, California · Not yet recruiting
Research Site
Gardena, California · Recruiting
Research Site
Lincoln, California · Recruiting
Research Site
Torrance, California · Not yet recruiting
Research Site
Walnut Creek, California · Not yet recruiting
Research Site
Doral, Florida · Not yet recruiting
Research Site
Fleming Island, Florida · Not yet recruiting
Research Site
Fort Lauderdale, Florida · Not yet recruiting
Research Site
Ocoee, Florida · Recruiting
Research Site
Woodstock, Georgia · Recruiting
Research Site
Chicago, Illinois · Not yet recruiting
Research Site
Melrose Park, Illinois · Not yet recruiting
Research Site
Oak Brook, Illinois · Not yet recruiting
Research Site
Ames, Iowa · Not yet recruiting
Research Site
Lenexa, Kansas · Recruiting
Research Site
Newton, Kansas · Not yet recruiting
Research Site
Monroe, Louisiana · Not yet recruiting
Research Site
Beltsville, Maryland · Not yet recruiting
Research Site
Lanham, Maryland · Not yet recruiting
Research Site
Oxon Hill, Maryland · Not yet recruiting
Research Site
Rockville, Maryland · Not yet recruiting
Research Site
North Dartmouth, Massachusetts · Not yet recruiting
Research Site
Farmington Hills, Michigan · Not yet recruiting
Research Site
Fayette, Mississippi · Not yet recruiting
Research Site
Kansas City, Missouri · Not yet recruiting
Research Site
Kansas City, Missouri · Not yet recruiting
Research Site
St Louis, Missouri · Not yet recruiting
Research Site
Omaha, Nebraska · Not yet recruiting
Research Site
Omaha, Nebraska · Not yet recruiting
Research Site
Eatontown, New Jersey · Not yet recruiting
Research Site
Somerset, New Jersey · Not yet recruiting
Research Site
Warren Township, New Jersey · Not yet recruiting
Research Site
Greensboro, North Carolina · Withdrawn
Showing 40 of 230 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.